Respiratory system | |||||
---|---|---|---|---|---|
Respiratory system / Respiratory depression, respiratory distress syndrome and apnoea | |||||
doxapram hydrochloride | Hospital only | ||||
Solution for injection | |||||
Doxapram hydrochloride (Non-proprietary) | Hospital only | ||||
Respiratory system / Airways disease, obstructive | |||||
aclidinium bromide | Specialist knowledge/initiation | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Inhalation powder | |||||
Eklira (Covis Pharma GmbH) | Specialist knowledge/initiation | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
aclidinium bromide with formoterol | Specialist knowledge/initiation | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Inhalation powder | |||||
Duaklir (Covis Pharma GmbH) | Specialist knowledge/initiation | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
aminophylline | Specialist knowledge/initiation | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Aminophylline (Non-proprietary) | Hospital only | ||||
beclometasone dipropionate | Joint formulary choice | ||||
Modified-release tablet | |||||
Clipper (Chiesi Ltd) | |||||
Pressurised inhalation | |||||
Beclu (Lupin Healthcare (UK) Ltd) | |||||
Clenil Modulite (Chiesi Ltd) | |||||
Kelhale (Cipla EU Ltd) | |||||
Qvar (Teva UK Ltd) | |||||
Qvar Autohaler (Teva UK Ltd) | |||||
Qvar Easi-Breathe (Teva UK Ltd) | |||||
Soprobec (Glenmark Pharmaceuticals Europe Ltd) | |||||
Inhalation powder | |||||
Easyhaler (Orion Pharma (UK) Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Spray | |||||
Beclometasone dipropionate (Non-proprietary) | |||||
Beconase (GlaxoSmithKline UK Ltd, Omega Pharma Ltd) | |||||
Nasobec (Teva UK Ltd) | |||||
Cutaneous ointment | |||||
Beclometasone dipropionate (Non-proprietary) | |||||
Cutaneous cream | |||||
Beclometasone dipropionate (Non-proprietary) | |||||
beclometasone with formoterol | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Pressurised inhalation | |||||
Beclometasone with formoterol (Non-proprietary) | |||||
Bibecfo (Cipla EU Ltd) | |||||
Fostair (Chiesi Ltd) | |||||
Luforbec (Lupin Healthcare (UK) Ltd) | |||||
Inhalation powder | |||||
Fostair NEXThaler (Chiesi Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
beclometasone with formoterol and glycopyrronium | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Joint Prescribing Group (JPG) decision
February 2018 - The JPG agreed to approve the addition of Trimbow® (beclometasone with formoterol and glycopyrronium combination inhaler) to the Joint Formulary. |
|||||
Pressurised inhalation | |||||
Trimbow (Chiesi Ltd) | |||||
Inhalation powder | |||||
Trimbow NEXThaler (Chiesi Ltd) | |||||
benralizumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA565 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Solution for injection | |||||
Fasenra (AstraZeneca UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
budesonide | Joint formulary choice |
NICE TA708 NICE TA937 |
|||
Orodispersible tablet | |||||
Jorveza (Dr. Falk Pharma UK Ltd) | |||||
Modified-release tablet | |||||
Cortiment (Ferring Pharmaceuticals Ltd) | |||||
Modified-release capsule | |||||
Budesonide (Non-proprietary) | |||||
Kinpeygo (Genus Pharmaceuticals Holdings Ltd) | |||||
Gastro-resistant capsule | |||||
Budenofalk (Dr. Falk Pharma UK Ltd) | |||||
Gastro-resistant granules | |||||
Budenofalk (Dr. Falk Pharma UK Ltd) | |||||
Inhalation powder | |||||
Budelin Novolizer (Viatris UK Healthcare Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Easyhaler (Orion Pharma (UK) Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Pulmicort Turbohaler (AstraZeneca UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Nebuliser liquid | |||||
Budesonide (Non-proprietary) | Specialist knowledge/initiation | ||||
Pulmicort Respules (AstraZeneca UK Ltd) | Specialist knowledge/initiation | ||||
Enema | |||||
Entocort (Tillotts Pharma UK Ltd) | |||||
Spray | |||||
Budesonide (Non-proprietary) | |||||
Rectal foam | |||||
Budenofalk (Dr. Falk Pharma UK Ltd) | |||||
budesonide with formoterol | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Pressurised inhalation | |||||
Symbicort (AstraZeneca UK Ltd) | |||||
Inhalation powder | |||||
DuoResp Spiromax (Teva UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Fobumix Easyhaler (Orion Pharma (UK) Ltd) | Not approved for prescribing | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Symbicort Turbohaler (AstraZeneca UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
WockAIR (Wockhardt UK Ltd) | |||||
ciclesonide | Not approved for prescribing | ||||
Pressurised inhalation | |||||
Alvesco (Covis Pharma GmbH) | |||||
dupilumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA534 NICE TA751 NICE TA955 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Solution for injection | |||||
Dupixent (Sanofi) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
ephedrine hydrochloride | Not approved for prescribing | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Ephedrine hydrochloride (Non-proprietary) | |||||
Oral tablet | |||||
Ephedrine hydrochloride (Non-proprietary) | |||||
fluticasone | Joint formulary choice | ||||
Pressurised inhalation | |||||
Flixotide Evohaler (GlaxoSmithKline UK Ltd) | |||||
Inhalation powder | |||||
Flixotide Accuhaler (GlaxoSmithKline UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Spray | |||||
Fluticasone (Non-proprietary) | |||||
Avamys (GlaxoSmithKline UK Ltd) | |||||
Coryen (Alissa Healthcare Research Ltd) | |||||
Flixonase (GlaxoSmithKline UK Ltd, Haleon UK Trading Ltd) | |||||
Nasofan (Teva UK Ltd) | |||||
Nasal drops | |||||
Fluticasone (Non-proprietary) | |||||
Cutaneous ointment | |||||
Cutivate (GlaxoSmithKline UK Ltd) | |||||
Cutaneous cream | |||||
Fluticasone (Non-proprietary) | |||||
fluticasone with formoterol | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Pressurised inhalation | |||||
Flutiform (Napp Pharmaceuticals Ltd) | |||||
fluticasone with salmeterol | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Pressurised inhalation | |||||
AirFluSal (Sandoz Ltd) | |||||
Aloflute (Viatris UK Healthcare Ltd) | |||||
Avenor (Zentiva Pharma UK Ltd) | |||||
Combisal (Aspire Pharma Ltd) | |||||
Sereflo (Cipla EU Ltd) | |||||
Seretide Evohaler (GlaxoSmithKline UK Ltd) | |||||
Sirdupla (Viatris UK Healthcare Ltd) | |||||
Inhalation powder | |||||
AirFluSal Forspiro (Sandoz Ltd) | Not approved for prescribing | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Campona Airmaster (Genesis Pharmaceuticals Ltd) | |||||
Fixkoh Airmaster (Genus Pharmaceuticals Holdings Ltd) | |||||
Fusacomb Easyhaler (Orion Pharma (UK) Ltd) | |||||
Sereflo Ciphaler (Cipla EU Ltd) | |||||
Seretide Accuhaler (GlaxoSmithKline UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Stalpex (Glenmark Pharmaceuticals Europe Ltd) | |||||
fluticasone with umeclidinium and vilanterol | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Inhalation powder | |||||
Trelegy Ellipta (GlaxoSmithKline UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
fluticasone with vilanterol | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Inhalation powder | |||||
Relvar Ellipta (GlaxoSmithKline UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
formoterol fumarate | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Pressurised inhalation | |||||
Atimos Modulite (Chiesi Ltd) | |||||
Inhalation powder | |||||
Easyhaler (Orion Pharma (UK) Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Oxis Turbohaler (AstraZeneca UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
formoterol fumarate with glycopyrronium and budesonide | |||||
Pressurised inhalation | |||||
Formoterol fumarate with glycopyrronium and budesonide (Non-proprietary) | |||||
glycopyrronium bromide | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Glycopyrronium bromide (Non-proprietary) | |||||
Inhalation powder | |||||
Seebri Breezhaler (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
glycopyrronium with formoterol fumarate | |||||
Pressurised inhalation | |||||
Bevespi Aerosphere (AstraZeneca UK Ltd) | |||||
glycopyrronium with indacaterol | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Inhalation powder | |||||
Ultibro Breezhaler (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
human alpha<sub>1</sub>-proteinase inhibitor | Not approved for prescribing | ||||
Powder and solvent for solution for infusion | |||||
Respreeza (CSL Behring UK Ltd) | Not approved for prescribing | ||||
indacaterol | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Inhalation powder | |||||
Onbrez Breezhaler (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
indacaterol with mometasone furoate | |||||
Inhalation powder | |||||
Atectura Breezhaler (Novartis Pharmaceuticals UK Ltd) | |||||
ipratropium bromide | Joint formulary choice | ||||
Pressurised inhalation | |||||
Atrovent (Boehringer Ingelheim Ltd) | |||||
Inhalvent (Alissa Healthcare Research Ltd) | |||||
Nebuliser liquid | |||||
Ipratropium bromide (Non-proprietary) | |||||
Atrovent UDV (Boehringer Ingelheim Ltd) | |||||
Spray | |||||
Ipratropium bromide (Non-proprietary) | |||||
ipratropium with salbutamol | Not approved for prescribing | ||||
Nebuliser liquid | |||||
Combiprasal (TriOn Pharma Ltd) | |||||
Combivent (Boehringer Ingelheim Ltd) | |||||
Ipramol (Teva UK Ltd) | |||||
mepolizumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA671 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
Solution for injection | |||||
Nucala (GlaxoSmithKline UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Powder for solution for injection | |||||
Nucala (GlaxoSmithKline UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
mometasone furoate | Joint formulary choice | ||||
Inhalation powder | |||||
Asmanex Twisthaler (Organon Pharma (UK) Ltd) | Joint formulary choice | ||||
Spray | |||||
Mometasone furoate (Non-proprietary) | |||||
Nasonex (Organon Pharma (UK) Ltd) | |||||
Cutaneous ointment | |||||
Mometasone furoate (Non-proprietary) | |||||
Elocon (Organon Pharma (UK) Ltd) | |||||
Cutaneous cream | |||||
Mometasone furoate (Non-proprietary) | |||||
Elocon (Organon Pharma (UK) Ltd) | |||||
Cutaneous liquid | |||||
Elocon (Organon Pharma (UK) Ltd) | |||||
mometasone furoate with glycopyrronium bromide and indacaterol | |||||
Inhalation powder | |||||
Enerzair Breezhaler (Novartis Pharmaceuticals UK Ltd) | |||||
montelukast | Joint formulary choice | ||||
Chewable tablet | |||||
Montelukast (Non-proprietary) | Joint formulary choice | ||||
Singulair (Organon Pharma (UK) Ltd) | Joint formulary choice | ||||
Oral tablet | |||||
Montelukast (Non-proprietary) | |||||
Singulair (Organon Pharma (UK) Ltd) | |||||
Oral granules | |||||
Montelukast (Non-proprietary) | |||||
Singulair (Organon Pharma (UK) Ltd) | |||||
olodaterol | Not approved for prescribing | ||||
Inhalation solution | |||||
Striverdi Respimat (Boehringer Ingelheim Ltd) | |||||
omalizumab | Hospital only |
NICE TA278 NICE TA339 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
Solution for injection | |||||
Xolair (Novartis Pharmaceuticals UK Ltd) | Hospital only | ||||
Xolair®
The JPG has approved the prescribing of this medicine at accredited specialist hospitals, provided that it is used in accordance to the relevant NICE Technology Appraisal. |
|||||
reslizumab | Hospital only |
NICE TA479 |
|||
Specialist Centre initiation
The Joint Prescribing Group agreed to approve this medicine for use at Homerton University Hospital Foundation Trust, provided it is initiated at a specialist centre and used specifically in accordance with the current relevant NICE Technology Appraisals (TAs). |
|||||
Solution for infusion | |||||
Cinqaero (Teva UK Ltd) | Hospital only | ||||
Specialist Centre initiation
The Joint Prescribing Group agreed to approve this medicine for use at Homerton University Hospital Foundation Trust, provided it is initiated at a specialist centre and used specifically in accordance with the current relevant NICE Technology Appraisals (TAs). |
|||||
roflumilast | Specialist knowledge/initiation |
NICE TA461 |
|||
ROFLUMILAST
This medication should be initiated by a specialist in respiratory medicine. |
|||||
Oral tablet | |||||
Roflumilast (Non-proprietary) | |||||
Daxas (AstraZeneca UK Ltd) | |||||
salbutamol | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Ventolin (GlaxoSmithKline UK Ltd) | Hospital only | ||||
Solution for infusion | |||||
Ventolin (GlaxoSmithKline UK Ltd) | Hospital only | ||||
Pressurised inhalation | |||||
Airomir (Teva UK Ltd) | |||||
Airomir Autohaler (Teva UK Ltd) | |||||
Salamol (Teva UK Ltd) | |||||
Salamol Easi-Breathe (Teva UK Ltd) | |||||
Ventolin Evohaler (GlaxoSmithKline UK Ltd) | |||||
Inhalation powder | |||||
Easyhaler (Orion Pharma (UK) Ltd) | Joint formulary choice | ||||
Salbulin Novolizer (Viatris UK Healthcare Ltd) | Joint formulary choice | ||||
Ventolin Accuhaler (GlaxoSmithKline UK Ltd) | Joint formulary choice | ||||
Nebuliser liquid | |||||
Salbutamol (Non-proprietary) | |||||
Brodilaten (Kent Pharma (UK) Ltd) | |||||
Ventolin (GlaxoSmithKline UK Ltd) | |||||
salmeterol | Joint formulary choice | ||||
Pressurised inhalation | |||||
Serevent Evohaler (GlaxoSmithKline UK Ltd) | |||||
Soltel (Cipla EU Ltd) | |||||
Inhalation powder | |||||
Serevent Accuhaler (GlaxoSmithKline UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
terbutaline sulfate | Joint formulary choice | ||||
Solution for injection | |||||
Bricanyl (AstraZeneca UK Ltd) | Hospital only | ||||
Inhalation powder | |||||
Bricanyl Turbohaler (AstraZeneca UK Ltd) | Joint formulary choice | ||||
Nebuliser liquid | |||||
Terbutaline sulfate (Non-proprietary) | |||||
Bricanyl Respules (AstraZeneca UK Ltd) | |||||
Oral tablet | |||||
Bricanyl (AstraZeneca UK Ltd) | |||||
tezepelumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA880 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Solution for injection | |||||
Tezspire (AstraZeneca UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
theophylline | Specialist knowledge/initiation | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Modified-release tablet | |||||
Uniphyllin Continus (Ennogen Healthcare Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
tiotropium | Joint formulary choice | ||||
TIOTROPIUM
Braltus Zonda® 10 micrograms inhalation powder is bioequivalent to Tiotropium Handihaler® 18 micrograms. Braltus Zonda® is the formulary choice tiotropium inhalation powder for initiation in new patients. |
|||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Inhalation powder | |||||
Acopair (Viatris UK Healthcare Ltd) | |||||
Braltus (Teva UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Spiriva (Boehringer Ingelheim Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Tiogiva (Glenmark Pharmaceuticals Europe Ltd) | |||||
Inhalation solution | |||||
Spiriva Respimat (Boehringer Ingelheim Ltd) | |||||
tiotropium with olodaterol | |||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Inhalation solution | |||||
Spiolto Respimat (Boehringer Ingelheim Ltd) | |||||
umeclidinium | Specialist knowledge/initiation | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Inhalation powder | |||||
Incruse Ellipta (GlaxoSmithKline UK Ltd) | Specialist knowledge/initiation | ||||
umeclidinium with vilanterol | Specialist knowledge/initiation | ||||
Prescribe by brand
Please prescribe this product by brand to avoid dispensing and administration errors. |
|||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Inhalation powder | |||||
Anoro Ellipta (GlaxoSmithKline UK Ltd) | Specialist knowledge/initiation | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Respiratory system / Cough and congestion | |||||
citric acid | Not approved for prescribing | ||||
Oral solution | |||||
Citric acid (Non-proprietary) | Not approved for prescribing | ||||
codeine phosphate | Specialist knowledge/initiation | ||||
Oral solution | |||||
Codeine phosphate (Non-proprietary) | Specialist knowledge/initiation | ||||
Galcodine (Thornton & Ross Ltd) | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Codeine phosphate (Non-proprietary) | |||||
eucalyptus with menthol | Not approved for prescribing | ||||
methadone hydrochloride | Hospital only |
NICE TA114 |
|||
Oral solution | |||||
Methadone hydrochloride (Non-proprietary) | Hospital only | ||||
Methadose (Rosemont Pharmaceuticals Ltd) | Hospital only | ||||
Metharose (Rosemont Pharmaceuticals Ltd) | Hospital only | ||||
Physeptone (Martindale Pharmaceuticals Ltd) | Hospital only | ||||
Solution for injection | |||||
Methadone hydrochloride (Non-proprietary) | Hospital only | ||||
Parenteral methadone
Parenteral methadone should only be prescribed in secondary care by or under the explicit direction of a specialist. |
|||||
Oral tablet | |||||
Methadone hydrochloride (Non-proprietary) | |||||
morphine | Specialist knowledge/initiation | ||||
Orodispersible tablet | |||||
Actimorph (Ethypharm UK Ltd) | |||||
Modified-release tablet | |||||
MST Continus (Napp Pharmaceuticals Ltd) | |||||
Morphgesic SR (Advanz Pharma) | |||||
Modified-release capsule | |||||
MXL (Napp Pharmaceuticals Ltd) | |||||
Zomorph (Ethypharm UK Ltd) | |||||
Oral solution | |||||
Morphine (Non-proprietary) | Specialist knowledge/initiation | ||||
Oramorph (Glenwood GmbH) | Specialist knowledge/initiation | ||||
Solution for injection | |||||
Morphine (Non-proprietary) | |||||
Infusion | |||||
Morphine (Non-proprietary) | |||||
Solution for infusion | |||||
Morphine (Non-proprietary) | |||||
Oral tablet | |||||
Sevredol (Napp Pharmaceuticals Ltd) | |||||
Respiratory system / Allergic conditions | |||||
BIRCH POLLEN EXTRACT (ITULAZAX) | Hospital only | ||||
North East London Formulary & Pathways Group’s Decision
February 2023 - The North East London Formulary & Pathways Group (FPG) approved the use of Itulazax in adult patients for the treatment of moderate-to-severe allergic rhinitis and/or conjunctivitis induced by pollen from the birch homologous group. This treatment should only be prescribed by the allergy team. |
|||||
acrivastine | Not approved for prescribing | ||||
Oral capsule | |||||
Acrivastine (Non-proprietary) | |||||
Benadryl Allergy Relief (McNeil Products Ltd) | |||||
alimemazine tartrate | Not approved for prescribing | ||||
Oral solution | |||||
Alimemazine tartrate (Non-proprietary) | Not approved for prescribing | ||||
Alfresed (Syri Ltd) | |||||
Itzenal (Zentiva Pharma UK Ltd) | |||||
Oral tablet | |||||
Alimemazine tartrate (Non-proprietary) | |||||
bee venom extract | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA246 |
|||
bilastine | Not approved for prescribing | ||||
Oral tablet | |||||
Ilaxten (A. Menarini Farmaceutica Internazionale SRL) | |||||
cetirizine hydrochloride | Joint formulary choice | ||||
Oral solution | |||||
Cetirizine hydrochloride (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Cetirizine hydrochloride (Non-proprietary) | Joint formulary choice | ||||
chlorphenamine maleate | Joint formulary choice | ||||
Oral solution | |||||
Chlorphenamine maleate (Non-proprietary) | Joint formulary choice | ||||
Allerief (Crescent Pharma Ltd) | Joint formulary choice | ||||
Prescribe generically
. |
|||||
Piriton (Haleon UK Trading Ltd) | Joint formulary choice | ||||
Prescribe generically
. |
|||||
Solution for injection | |||||
Chlorphenamine maleate (Non-proprietary) | Hospital only | ||||
Oral tablet | |||||
Chlorphenamine maleate (Non-proprietary) | Joint formulary choice | ||||
Allerief (Crescent Pharma Ltd) | |||||
Hayleve (Genesis Pharmaceuticals Ltd) | |||||
Piriton (Haleon UK Trading Ltd) | |||||
cyproheptadine hydrochloride | Not approved for prescribing | ||||
Oral tablet | |||||
Periactin (Teva UK Ltd) | |||||
desloratadine | Not approved for prescribing | ||||
Oral solution | |||||
Desloratadine (Non-proprietary) | Not approved for prescribing | ||||
Neoclarityn (Organon Pharma (UK) Ltd) | Not approved for prescribing | ||||
Oral tablet | |||||
Desloratadine (Non-proprietary) | |||||
Neoclarityn (Organon Pharma (UK) Ltd) | |||||
fexofenadine hydrochloride | Joint formulary choice | ||||
Oral tablet | |||||
Fexofenadine hydrochloride (Non-proprietary) | |||||
Telfast (Sanofi Consumer Healthcare) | |||||
grass pollen extract | Hospital only | ||||
Oral lyophilisate | |||||
Grazax (ALK-Abello Ltd) | Hospital only | ||||
Form unstated | |||||
Pollinex Grasses + Rye (Allergy Therapeutics (UK) Ltd) | Hospital only | ||||
house dust mite extract | Hospital only | ||||
North East London Formulary & Pathways Group's Decision
December 2022 - The North East London Formulary & Pathways Group (FPG) approved the use of Acarizax® 12 SQ-HDM oral lyophilisates for the management of house dust mite allergic rhinitis in patients 12 years and above. This treatment should only be prescribed by the allergy team. |
|||||
Oral lyophilisate | |||||
Acarizax (ALK-Abello Ltd) | Hospital only | ||||
North East London Formulary & Pathways Group's Decision
December 2022 - The North East London Formulary & Pathways Group (FPG) approved the use of Acarizax® 12 SQ-HDM oral lyophilisates for the management of house dust mite allergic rhinitis in patients 12 years and above. This treatment should only be prescribed by the allergy team. |
|||||
hydroxyzine hydrochloride | Joint formulary choice | ||||
Oral tablet | |||||
Hydroxyzine hydrochloride (Non-proprietary) | |||||
ketotifen | Not approved for prescribing | ||||
Oral solution | |||||
Zaditen (CD Pharma Srl) | Not approved for prescribing | ||||
Eye drops | |||||
Ketofall (Scope Ophthalmics Ltd) | |||||
Zaditen (Thea Pharmaceuticals Ltd) | Not approved for prescribing | ||||
Oral tablet | |||||
Zaditen (CD Pharma Srl) | |||||
levocetirizine hydrochloride | Not approved for prescribing | ||||
Oral solution | |||||
Xyzal (UCB Pharma Ltd) | Not approved for prescribing | ||||
Oral tablet | |||||
Levocetirizine hydrochloride (Non-proprietary) | |||||
Xyzal (UCB Pharma Ltd) | |||||
loratadine | Joint formulary choice | ||||
Oral solution | |||||
Loratadine (Non-proprietary) | Joint formulary choice | ||||
Oral tablet | |||||
Loratadine (Non-proprietary) | Joint formulary choice | ||||
mizolastine | Not approved for prescribing | ||||
Modified-release tablet | |||||
Mizollen (Sanofi Consumer Healthcare) | Not approved for prescribing | ||||
peanut protein | Hospital only | ||||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Form unstated | |||||
Palforzia (Stallergenes Greer Ltd) | Hospital only | ||||
Oral powder | |||||
Palforzia (Stallergenes Greer Ltd) | |||||
promethazine hydrochloride | Joint formulary choice | ||||
Oral solution | |||||
Phenergan (Sanofi Consumer Healthcare) | Joint formulary choice | ||||
Solution for injection | |||||
Phenergan (Sanofi Consumer Healthcare) | Hospital only | ||||
Oral tablet | |||||
Promethazine hydrochloride (Non-proprietary) | |||||
Phenergan (Sanofi Consumer Healthcare) | |||||
Sominex (Dexcel-Pharma Ltd) | |||||
rupatadine | Not approved for prescribing | ||||
Oral tablet | |||||
Rupatadine (Non-proprietary) | |||||
tree pollen extract | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Suspension for injection | |||||
Pollinex Trees (Allergy Therapeutics (UK) Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Form unstated | |||||
Pollinex Trees (Allergy Therapeutics (UK) Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
wasp venom extract | Hospital only |
NICE TA246 |
|||
Joint Prescribing Group's decision
January 2020 - the JPG agreed to approve the addition of Alutard SQ® (bee venom and wasp venom suspension for injection) to the joint formulary for the management of Bee allergy. Treatment should be carried out under the supervision of a doctor experienced in specific immunotherapy. |
|||||
Respiratory system / Anaphylaxis | |||||
adrenaline/epinephrine | Joint formulary choice | ||||
Epipen®, Emerade® and Jext® are not used in exactly the same way
Please note different brands of adrenaline auto-injectors are not used in exactly the same way - specific training and advice is required for each of the devices. |
|||||
Solution for injection | |||||
Adrenaline/epinephrine (Non-proprietary) | Hospital only | ||||
EpiPen (Viatris UK Healthcare Ltd) | Joint formulary choice | ||||
Jext (ALK-Abello Ltd) | Joint formulary choice | ||||
chlorphenamine maleate | Joint formulary choice | ||||
Oral solution | |||||
Chlorphenamine maleate (Non-proprietary) | Joint formulary choice | ||||
Allerief (Crescent Pharma Ltd) | Joint formulary choice | ||||
Piriton (Haleon UK Trading Ltd) | Joint formulary choice | ||||
Solution for injection | |||||
Chlorphenamine maleate (Non-proprietary) | Hospital only | ||||
Oral tablet | |||||
Chlorphenamine maleate (Non-proprietary) | Joint formulary choice | ||||
Allerief (Crescent Pharma Ltd) | |||||
Hayleve (Genesis Pharmaceuticals Ltd) | |||||
Piriton (Haleon UK Trading Ltd) | |||||
Respiratory system / Angioedema | |||||
C1-esterase inhibitor | Hospital only | ||||
Powder and solvent for solution for injection | |||||
Berinert P (CSL Behring UK Ltd) | Hospital only | ||||
Cinryze (Takeda UK Ltd) | Hospital only | ||||
berotralstat | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA738 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Oral capsule | |||||
Orladeyo (BioCryst Ireland Ltd) | |||||
conestat alfa | Hospital only | ||||
Powder for solution for injection | |||||
Ruconest (Pharming Group N.V.) | Hospital only | ||||
Powder and solvent for solution for injection | |||||
Ruconest (Pharming Group N.V.) | |||||
icatibant | Hospital only | ||||
Solution for injection | |||||
Icatibant (Non-proprietary) | |||||
Firazyr (Takeda UK Ltd) | Hospital only | ||||
lanadelumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA606 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Solution for injection | |||||
Lanadelumab (Non-proprietary) | |||||
Takhzyro (Takeda UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Respiratory system / Conditions affecting sputum viscosity | |||||
acetylcysteine | Not approved for prescribing | ||||
Effervescent tablet | |||||
Acetylcysteine (Non-proprietary) | Not approved for prescribing | ||||
A-CYS (Ennogen Healthcare Ltd) | Not approved for prescribing | ||||
AceCil (Essential-Healthcare Ltd) | |||||
Acepiro (Stirling Anglian Pharmaceuticals Ltd) | |||||
NACSYS (Alturix Ltd) | Not approved for prescribing | ||||
Solution for infusion | |||||
Acetylcysteine (Non-proprietary) | |||||
Parvolex (Phoenix Labs Ltd) | |||||
Eye drops | |||||
Ilube (Rayner Pharmaceuticals Ltd) | |||||
carbocisteine | Joint formulary choice | ||||
Oral solution | |||||
Carbocisteine (Non-proprietary) | Joint formulary choice | ||||
Mucodyne (Sanofi) | Joint formulary choice | ||||
Oral capsule | |||||
Carbocisteine (Non-proprietary) | |||||
erdosteine | Not approved for prescribing | ||||
Oral capsule | |||||
Erdotin (Galen Ltd) | |||||
Respiratory system / Cystic fibrosis | |||||
dornase alfa | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Nebuliser liquid | |||||
Pulmozyme (Roche Products Ltd) | |||||
ivacaftor | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Oral tablet | |||||
Kalydeco (Vertex Pharmaceuticals (Europe) Ltd) | |||||
ivacaftor with tezacaftor and elexacaftor |
NICE TA988 |
||||
Oral tablet | |||||
Kaftrio (Vertex Pharmaceuticals (Europe) Ltd) | |||||
lumacaftor with ivacaftor | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA398 |
|||
Oral tablet | |||||
Orkambi (Vertex Pharmaceuticals (Europe) Ltd) | |||||
mannitol | Hospital only |
NICE TA266 |
|||
Infusion | |||||
Mannitol (Non-proprietary) | Hospital only | ||||
Inhalation powder | |||||
Mannitol (Non-proprietary) | Hospital only | ||||
Bronchitol (Chiesi Ltd) | Hospital only | ||||
tezacaftor with ivacaftor |
NICE TA988 |
||||
Oral tablet | |||||
Symkevi (Vertex Pharmaceuticals (Europe) Ltd) | |||||
Respiratory system / Interstitial lung disease | |||||
nintedanib | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA347 NICE TA379 NICE TA864 NICE TA747 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Oral capsule | |||||
Ofev (Boehringer Ingelheim Ltd) | |||||
Vargatef (Boehringer Ingelheim Ltd) | |||||
pirfenidone |
NICE TA504 |
||||
Oral tablet | |||||
Pirfenidone (Non-proprietary) | |||||
Esbriet (Roche Products Ltd) |